What is the most critical nursing assessment after administering IV thrombolytics for myocardial infarction?

GMCH Nursing Officer-2025

Medical & Surgical Nursing

Medium

Appeared in: GMCH Nursing Officer-2025

Explanation

Thrombolytic agents (e.g., alteplase) dissolve clots systemically, not just the one causing the myocardial infarction.
This systemic action creates a high risk of bleeding throughout the body, which is the most common and life-threatening complication.
Intracranial hemorrhage is the most feared complication and can be fatal. Therefore, monitoring for any sign of bleeding is the top priority for patient safety.
Early detection of bleeding allows for prompt intervention to prevent hemorrhagic shock and other severe outcomes.

Option A: Assessing respiratory effort is a standard part of patient care but does not address the primary, specific complication of thrombolytic therapy.
Option B: Monitoring for chest pain is important to evaluate the effectiveness of the therapy (reperfusion), but it is not as critical as monitoring for a life-threatening side effect.
Option D: Monitoring the ECG for resolution of ST elevation is also done to assess for successful reperfusion. However, the immediate, iatrogenic risk of hemorrhage is a higher priority from a safety standpoint.

Visual 1: Infographic: Common signs of bleeding to monitor in a patient receiving thrombolytics, including both overt (visible) and covert (internal) signs like petechiae, ecchymosis, hematuria, melena, and changes in mental status.
Visual 2: Flowchart: Decision-making process for a nurse when a patient on thrombolytics shows a change in neurological status, leading to immediate cessation of the drug and emergency notification.

Clinical Relevance

Nursing practice connection: Prioritize focused assessment, early escalation, and real-time monitoring when managing Priority nursing assessment following thrombolytic therapy in acute care settings.
A nurse's vigilance in monitoring for bleeding is the most critical factor in preventing a catastrophic outcome during thrombolytic therapy. This is a core patient safety responsibility.
Invasive procedures, including intramuscular injections and even automatic blood pressure cuff inflation, should be minimized to reduce the risk of bruising and hematoma formation.
What if? The patient reports a sudden, severe headache and becomes drowsy. The nurse's immediate action should be to stop the thrombolytic infusion, perform a rapid neurological assessment, notify the physician immediately, and prepare for an emergency CT scan to rule out intracranial hemorrhage.

How to Approach the Question

First, identify the question type. This is a priority-setting question, asking for the 'most critical' assessment.
Next, identify the core subject: IV thrombolytics for MI. Recall the mechanism of action and the most significant side effects of this drug class.
Thrombolytics work by breaking down clots, but they do so throughout the body, not just in the heart. This leads to a major risk of bleeding.
Evaluate each option based on the ABCs (Airway, Breathing, Circulation) and the risk versus benefit principle. While all options are valid assessments, which one addresses the most immediate, life-threatening complication caused by the medication?
Monitoring for chest pain and ECG changes assesses the benefit (effectiveness) of the drug. Assessing for bleeding monitors for the most severe risk.
In priority questions, patient safety and managing life-threatening complications often take precedence over evaluating treatment effectiveness. Therefore, checking for signs of bleeding is the highest priority.

Concept Tested & Keywords

QiuRNXeygwyPIzwi8g5GAA